Skip to content
Web Asset HouseAI Prescribing Watch
Menu

Informational only. Not affiliated with any government agency. Verify details at the official source.

Devices · Ultrasound AI

Delivery Date AI

De NovoDEN250007RadiologySHE

Ultrasound AI is listed for Delivery Date AI (DEN250007). The FDA list gives February 11, 2026 as the date of the final decision. The lead panel is Radiology, and the database link on the FDA list is the De Novo pathway. openFDA describes product code SHE as “Radiological Software System For Delivery Date Prediction”: A radiological software system for delivery date prediction is a software-only device that analyzes obstetric radiological images to predict the delivery date of a pregnancy. The device output does not replace a clinician's review or judgment on the progression of a pregnancy and should be used in conjunction with other clinical and diagnostic findings. The device does not identify at-risk pregnancies or identify specific complications. openFDA records this submission’s decision description as “Unknown.” This paragraph is assembled only from those public fields. It is not an FDA review, not a determination of safety or effectiveness, and not medical advice. Official record: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN250007

Official FDA database record

Date of final decision
February 11, 2026
Company on the FDA list
Ultrasound AI
Lead panel
Radiology
Primary product code
SHE
openFDA device name for the code
Radiological Software System For Delivery Date Prediction
Device class
2
Regulation number
892.8200
openFDA decision description
Unknown
openFDA decision code
DENG
Statement or summary label
Not returned

Product-code text from openFDA

A radiological software system for delivery date prediction is a software-only device that analyzes obstetric radiological images to predict the delivery date of a pregnancy. The device output does not replace a clinician's review or judgment on the progression of a pregnancy and should be used in conjunction with other clinical and diagnostic findings. The device does not identify at-risk pregnancies or identify specific complications.